Accelerated Waning of Protective Immunity After SARS-CoV-2 mRNA Vaccination in Patients Treated with Biological and Targeted Synthetic Disease Modifying Antirheumatic Drugs

被引：0
|
作者：
Simader, Elisabeth [1 ]
Tobudic, Selma [2 ]
Deimel, Thomas [3 ]
Mandl, Peter [4 ]
Haslacher, Helmuth [5 ]
Perkmann, Thomas [5 ]
Schneider, Lisa [6 ]
Nothnagl, Thomas [7 ]
Radner, Helga [1 ]
Winkler, Florian [2 ]
Burgmann, Heinz [2 ]
Stiasny, Karin [8 ]
Novacek, Gottfried [9 ]
Reinisch, Walter [10 ]
Aletaha, Daniel [11 ]
Winkler, Stefan [2 ]
Blueml, Stephan [1 ]
机构：
[1] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria
[2] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Internal Med 1, Vienna, Austria
[3] Med Univ Vienna, Vienna, Austria
[4] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria
[5] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[6] Med Univ Vienna, Dept Internal Med 1, Div Infect Dis & Trop Med, Vienna, Austria
[7] Korneuburg Stockerau Hosp, Med Dept 2, Lower Austrian Ctr Rheumatol, Stockerau, Austria
[8] Med Univ Vienna, Ctr Virol, Vienna, Austria
[9] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
[10] Med Univ Vienna, Div Gastroenterol & Hepatol, Vienna, Austria
[11] Med Univ Vienna, Vienna, Austria
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0932
引用
收藏
页码：1840 / 1842
页数：3
相关论文
共 50 条
  • [41] Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease
    Melmed, Gil Y.
    Sobhani, Kimia
    Li, Dalin
    Prostko, John
    Figueiredo, Jane
    Cheng, Susan
    Braun, Jonathan
    McGovern, Dermot P. B.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (12) : 1768 - +
  • [42] SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
    Selim, Rania
    Wellens, Judith
    Marlow, Luke
    Satsangi, Jack J.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 989 - 989
  • [43] Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010
    Ichinose, Kunihiro
    Shimizu, Toshimasa
    Umeda, Masataka
    Fukui, Shoichi
    Nishino, Ayako
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Tamai, Mami
    Nakamura, Hideki
    Sato, Shuntaro
    Origuchi, Tomoki
    Kawakami, Atsushi
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [44] Comment on: mRNA SARS-CoV-2 vaccination in patients after allogeneic hematopoietic cell transplantation
    Mungmunpuntipantip, R.
    Wiwanitkti, Viroj
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (03)
  • [45] Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
    Meylan, Sylvain
    Livio, Francoise
    Foerster, Maryline
    Genoud, Patrick James
    Marguet, Francois
    Wuerzner, Gregoire
    HYPERTENSION, 2021, 77 (06) : E56 - E57
  • [46] Predictors of Gross Hematuria After SARS-CoV-2 mRNA Vaccination in Patients with IgA Nephropathy
    Yokote, Shinya
    Tsuboi, Nobuo
    Shimizu, Akihiro
    Okabe, Masahiro
    Haruhara, Kotaro
    Sasaki, Takaya
    Ueda, Hiroyuki
    Yokoo, Takashi
    KIDNEY360, 2023, 4 (07): : 943 - 950
  • [47] Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies
    Romero-Bogado, Liz
    Steiner, Martina
    Vasallo, Israel John Thuissard
    Andreu-Vazquez, Cristina
    Cobo-Ibanez, Tatiana
    Gomez, Alejandro Gomez
    Paredes-Romero, Maria Beatriz
    Esteban-Vazquez, Ana
    Mendez, Laura Cebrian
    De La Mano, Maria Angeles Matias
    Garcia-Yubero, Cristina
    Hernandez, Alicia Martinez
    Ortega, Mar Esteban
    Marcos, Noemi Mancenido
    Pajares, Ramon
    Alba, Concepcion Esteban
    Santos, Raquel Guillen
    Marcos, Teresa Navio
    Munoz-Fernandez, Santiago
    REVISTA CHILENA DE INFECTOLOGIA, 2023, 40 (06): : 618 - 625
  • [48] Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients
    Berar-Yanay, Noa
    Freiman, Sarit
    Shapira, MaMODIFIER L. E. T. T. E. R. PRIMEanit
    Saffoury, Amer
    Elemy, Ameer
    Hamze, Munir
    Elhaj, Mohamad
    Zaher, Maha
    Matanis, Loai
    Armaly, Zaher Anis
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [49] Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis
    Auroux, Maxime
    Laurent, Benjamin
    Coste, Baptiste
    Massy, Emmanuel
    Mercier, Alexandre
    Durieu, Isabelle
    Confavreux, Cyrille B.
    Lega, Jean-Christophe
    Mainbourg, Sabine
    Coury, Fabienne
    JOINT BONE SPINE, 2022, 89 (05)
  • [50] Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis-2020 update
    Fernandes, B. M.
    Guimaraes, F.
    Almeida, D. E.
    Neto, A.
    Tavares-Costa, J.
    Ribeiro, A. R.
    Quintal, A.
    Pereira, J. P.
    Silva, L.
    Novoa, T. S.
    Faustino, A.
    Vaz, C.
    Khmelinskii, N.
    Samoes, B.
    Dourado, E.
    Silva, J. L.
    Barcelos, A.
    Mariz, E.
    Guerra, M.
    Santos, M. J.
    Silverio-Antonio, M.
    Teixeira, R. L.
    Romao, V. C.
    Santos, H.
    Santos-Faria, D.
    Azevedo, S.
    Rodrigues, A.
    Dias, J. M.
    Lopes, C.
    Pinto, P.
    Couto, M.
    Miranda, L. C.
    Bernardo, A.
    Cruz, M.
    Teixeira, F.
    Mourao, A. F.
    Neto, A.
    Teixeira, V
    Cordeiro, A.
    Barreira, S.
    Ines, L. S.
    Capela, S.
    Sepriano, A.
    Canhao, H.
    Fonseca, J. E.
    Duarte, C.
    Bernardes, M.
    ARP RHEUMATOLOGY, 2022, 1 (01): : 63 - 82
12345